​

Forte Biosciences (FBRX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

FBRX Stock Rating

Forte Biosciences stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (50.00%), 3 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 3 3 Strong Sell Sell Hold Buy Strong Buy

FBRX Price Target Upside V Benchmarks

TypeNameUpside
StockForte Biosciences-
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$13.46$13.46$13.46
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25-5---5
Sep, 25-5---5
Aug, 25-4---4
Jul, 25-4---4
Jun, 25-3---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 18, 2025GuggenheimBuyinitialise
Jun 18, 2024Rodman & RenshawBuyinitialise
May 29, 2024Brookline CapitalBuyinitialise

Financial Forecast

EPS Forecast

$-40 $-32 $-24 $-16 $-8 $0 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-38.85$-24.92$-12.17----
Avg Forecast$-34.75$-14.50$-9.44$-3.68$-2.77$-2.71$-2.26
High Forecast$-34.75$-14.50$-5.24$-3.44$-2.77$-2.71$-2.26
Low Forecast$-34.75$-14.50$-15.48$-4.03$-2.77$-2.71$-2.26
Surprise %11.80%71.86%28.92%----

Revenue Forecast

$5M $9M $13M $17M $21M $25M Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-------
Avg Forecast$9.59K---$9.00M$22.50M$21.12M
High Forecast$11.51K---$9.00M$22.50M$21.12M
Low Forecast$7.67K---$9.00M$22.50M$21.12M
Surprise %-------

Net Income Forecast

$-40M $-32M $-24M $-16M $-8M $0 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-21.71M$-31.48M$-35.48M----
Avg Forecast$-27.03M$-18.31M$-13.08M$-4.72M$-3.49M$-3.42M$-2.85M
High Forecast$-21.63M$-18.31M$-6.62M$-4.35M$-3.49M$-3.42M$-2.85M
Low Forecast$-32.44M$-18.31M$-19.55M$-5.09M$-3.49M$-3.42M$-2.85M
Surprise %-19.69%71.89%171.14%----

FBRX Forecast FAQ

Is Forte Biosciences stock a buy?

Forte Biosciences stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Forte Biosciences is a favorable investment for most analysts.

What is Forte Biosciences's price target?

Forte Biosciences's price target, set by 6 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $13.46.

How does Forte Biosciences stock forecast compare to its benchmarks?

Forte Biosciences's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Forte Biosciences over the past three months?

  • October 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Forte Biosciences’s EPS forecast?

Forte Biosciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-3.68, marking a -69.76% decrease from the reported $-12.17 in 2024. Estimates for the following years are $-2.77 in 2026, $-2.71 in 2027, and $-2.26 in 2028.

What is Forte Biosciences’s revenue forecast?

Forte Biosciences's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $9M, followed by $22.5M for 2027, and $21.12M for 2028.

What is Forte Biosciences’s net income forecast?

Forte Biosciences's net income forecast for the fiscal year ending in December 2025 stands at $-4.721M, representing a -86.69% decrease from the reported $-35.478M in 2024. Projections indicate $-3.492M in 2026, $-3.422M in 2027, and $-2.848M in 2028.